top of page

Bupivacaine study launches!

Coleman Research Group

Updated: Mar 14, 2021

The Bupivacaine study has officially launched! The first two participants will take part in the study this upcoming week.


Congratulations to the entire team for the hard work they have put into getting this study ready, and all the best for the next two years on this project! Anja Frost, MD, PG Y4 in the Gynecology & Obstetrics Residency Program at Johns Hopkins, is the lead investigator on this study. Karen Wang, MD, Fellowship Director of the Minimally Invasive Gynecologic Surgery (MIGS) program, is the principal investigator on the study, and Obianuju Okonkwo, BS, serves as the primary study coordinator.

Comments


Post: Blog2_Post
  • Facebook
  • Twitter
  • LinkedIn

©2023 by The Coleman Research Group. 

bottom of page